Related Experiment Videos
[Thromboembolism prevention in acute myocardial infarction]
C M Jiménez Martín1, J A Durán Quintana, J A Abadín Delgado
1Hospital Universitario Virgen Macarena, Sevilla.
Insights
This study identified immobility, heart failure, and advanced age as key risk factors for vein thromboembolic disease in acute myocardial infarction patients. Prophylaxis was inconsistently administered, regardless of patient risk factors.
Area of Science:
- Cardiology
- Vascular Medicine
- Thrombosis Research
Background:
- Vein thromboembolic disease (VTD) is a significant complication in patients with acute myocardial infarction (AMI).
- Effective thromboembolic prophylaxis is crucial for managing AMI patients at risk.
- Understanding specific risk factors and prophylaxis patterns is essential for improving patient outcomes.
Purpose of the Study:
- To identify prevalent risk factors for VTD in acute myocardial infarction (AMI) patients.
- To quantitatively and qualitatively analyze the thromboembolic prophylaxis administered to these patients.
- To determine if VTD prophylaxis is influenced by identified thromboembolic risk factors.
Main Methods:
- A cross-sectional study design was employed.
- Data were collected from all inpatients admitted to the Coronary Unit in 1998.
- Risk factors and prophylaxis administration were assessed for VTD risk in AMI patients.
Main Results:
- Immobilization (79.2%), heart failure (33.2%), and age over 70 years (31%) were identified as primary risk factors for VTD.
- Thromboembolic prophylaxis was administered in 86.9% of cases.
- Non-fractioned heparin (NFH) and low molecular weight heparins (LMWH) were common, with observed instances of over- and under-dosage.
- Prophylaxis administration was not correlated with the presence of thromboembolic risk factors.
Conclusions:
- Immobility, heart failure, and advanced age are significant VTD risk factors in AMI patients.
- While prophylaxis is frequently administered, its application is not guided by patient-specific risk factors.
- There is a need to align VTD prophylaxis strategies with identified thromboembolic risk factors in AMI management.
Abstract:
The objectives were to identify risk factors for vein thromboembolic disease (VTD) among patients with acute myocardial infarction (AMI) and to analyse both quantitatively and qualitatively the performed thromboembolic prophylaxis. A cross-sectional study was carried out with all inpatients at the Coronary Unit at our hospital during 1998. The risk factors for thromboembolism included: inmobilization (79.2%), heart failure (33.2%) and age over 70 years (31%). VTD prophylaxis was performed in 86.9% of the time. Non-fractioned heparin (NFH) and low molecular weight heparins (LMWH), mostly nadroparine, were the most commonly used drugs at admission and at discharge, respectively. Overdosage and underdosage for NFH and LMWH, respectively, were observed. That patients received or not VTD prophylaxis was not influenced by thromboembolic risk factors.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins